THSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation

Abstract Microglial activation, driven by a metabolic shift towards aerobic glycolysis, is implicated in neuroinflammation and neurological disorders like depression. THSG (2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside), derived from Polygonum multiflorum, exhibits anti-inflammatory and neuroprote...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhe Guo, Sijia Zhong, Jinpeng Bai, Xiuyuan Lang, Minmin Cao, Yang Hu, Xiaoyan Qin, Yingyu Sun
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-05994-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399688689614848
author Zhe Guo
Sijia Zhong
Jinpeng Bai
Xiuyuan Lang
Minmin Cao
Yang Hu
Xiaoyan Qin
Yingyu Sun
author_facet Zhe Guo
Sijia Zhong
Jinpeng Bai
Xiuyuan Lang
Minmin Cao
Yang Hu
Xiaoyan Qin
Yingyu Sun
author_sort Zhe Guo
collection DOAJ
description Abstract Microglial activation, driven by a metabolic shift towards aerobic glycolysis, is implicated in neuroinflammation and neurological disorders like depression. THSG (2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside), derived from Polygonum multiflorum, exhibits anti-inflammatory and neuroprotective properties, but its mechanisms, particularly its impact on microglial metabolism, are largely unexplored. Using a LPS-induced mouse model of neuroinflammation, we observed that THSG significantly ameliorated depression-like behaviors. It suppressed pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6, iNOS), inhibited microglial activation, and reduced key necroptosis markers (phosphorylated RIPK1, RIPK3, and MLKL) in the hippocampus. Importantly, THSG effectively suppressed LPS-induced activation of the glycolytic pathway in the hippocampus, as evidenced by increased ATP levels, decreased lactate levels, reduced activity of key glycolytic enzymes, and decreased expression of PKM2 and HIF-1α, critical players in microglial glycolysis. Further in vitro studies with BV2 microglial cells confirmed that THSG significantly suppressed glycolytic enhancement, promoting a metabolic shift towards oxidative phosphorylation, thus inhibiting inflammatory activation of microglia. Co-culture experiments of BV2 cells and SH-SY5Y cells further corroborated the in vivo findings, demonstrating that THSG mitigated inflammation-induced necroptosis in SH-SY5Y neurons by reducing phosphorylation of RIPK1, RIPK3, and MLKL, thus protecting neurons from damage. Our results highlight the potential of THSG as a therapeutic agent for neuroinflammatory disorders by modulating microglial metabolic reprogramming and inhibiting neuronal necroptosis.
format Article
id doaj-art-68c60f6de04b46de934a5e11f003f903
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-68c60f6de04b46de934a5e11f003f9032025-08-20T03:38:16ZengNature PortfolioScientific Reports2045-23222025-07-0115111410.1038/s41598-025-05994-yTHSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammationZhe Guo0Sijia Zhong1Jinpeng Bai2Xiuyuan Lang3Minmin Cao4Yang Hu5Xiaoyan Qin6Yingyu Sun7The Emergency Department, The Third Affiliated Hospital of Guangxi Medical UniversityKhoury College of Computer Sciences, Northeastern University Seattle CampusKey Laboratory of Ecology and Environment in Minority Areas National Ethnic Affairs Commission, Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of ChinaDepartment of Genetics and Genome Sciences, School of Medicine, Case Western Reserve UniversityKey Laboratory of Ecology and Environment in Minority Areas National Ethnic Affairs Commission, Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of ChinaKey Laboratory of Ecology and Environment in Minority Areas National Ethnic Affairs Commission, Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of ChinaKey Laboratory of Ecology and Environment in Minority Areas National Ethnic Affairs Commission, Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of ChinaBeijing Key Laboratory of Gene Resource and Molecular Development, College of Life Sciences, Beijing Normal UniversityAbstract Microglial activation, driven by a metabolic shift towards aerobic glycolysis, is implicated in neuroinflammation and neurological disorders like depression. THSG (2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside), derived from Polygonum multiflorum, exhibits anti-inflammatory and neuroprotective properties, but its mechanisms, particularly its impact on microglial metabolism, are largely unexplored. Using a LPS-induced mouse model of neuroinflammation, we observed that THSG significantly ameliorated depression-like behaviors. It suppressed pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6, iNOS), inhibited microglial activation, and reduced key necroptosis markers (phosphorylated RIPK1, RIPK3, and MLKL) in the hippocampus. Importantly, THSG effectively suppressed LPS-induced activation of the glycolytic pathway in the hippocampus, as evidenced by increased ATP levels, decreased lactate levels, reduced activity of key glycolytic enzymes, and decreased expression of PKM2 and HIF-1α, critical players in microglial glycolysis. Further in vitro studies with BV2 microglial cells confirmed that THSG significantly suppressed glycolytic enhancement, promoting a metabolic shift towards oxidative phosphorylation, thus inhibiting inflammatory activation of microglia. Co-culture experiments of BV2 cells and SH-SY5Y cells further corroborated the in vivo findings, demonstrating that THSG mitigated inflammation-induced necroptosis in SH-SY5Y neurons by reducing phosphorylation of RIPK1, RIPK3, and MLKL, thus protecting neurons from damage. Our results highlight the potential of THSG as a therapeutic agent for neuroinflammatory disorders by modulating microglial metabolic reprogramming and inhibiting neuronal necroptosis.https://doi.org/10.1038/s41598-025-05994-yTHSGNeuroinflammationMicrogliaMetabolic reprogrammingNecroptosisDepression
spellingShingle Zhe Guo
Sijia Zhong
Jinpeng Bai
Xiuyuan Lang
Minmin Cao
Yang Hu
Xiaoyan Qin
Yingyu Sun
THSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation
Scientific Reports
THSG
Neuroinflammation
Microglia
Metabolic reprogramming
Necroptosis
Depression
title THSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation
title_full THSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation
title_fullStr THSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation
title_full_unstemmed THSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation
title_short THSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation
title_sort thsg counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation
topic THSG
Neuroinflammation
Microglia
Metabolic reprogramming
Necroptosis
Depression
url https://doi.org/10.1038/s41598-025-05994-y
work_keys_str_mv AT zheguo thsgcounteractsmicroglialglycolyticreprogrammingandneuronalnecroptosisbothinvivoandinvitrounderconditionsofneuroinflammation
AT sijiazhong thsgcounteractsmicroglialglycolyticreprogrammingandneuronalnecroptosisbothinvivoandinvitrounderconditionsofneuroinflammation
AT jinpengbai thsgcounteractsmicroglialglycolyticreprogrammingandneuronalnecroptosisbothinvivoandinvitrounderconditionsofneuroinflammation
AT xiuyuanlang thsgcounteractsmicroglialglycolyticreprogrammingandneuronalnecroptosisbothinvivoandinvitrounderconditionsofneuroinflammation
AT minmincao thsgcounteractsmicroglialglycolyticreprogrammingandneuronalnecroptosisbothinvivoandinvitrounderconditionsofneuroinflammation
AT yanghu thsgcounteractsmicroglialglycolyticreprogrammingandneuronalnecroptosisbothinvivoandinvitrounderconditionsofneuroinflammation
AT xiaoyanqin thsgcounteractsmicroglialglycolyticreprogrammingandneuronalnecroptosisbothinvivoandinvitrounderconditionsofneuroinflammation
AT yingyusun thsgcounteractsmicroglialglycolyticreprogrammingandneuronalnecroptosisbothinvivoandinvitrounderconditionsofneuroinflammation